Concurrent chemo and radiation confers survival benefit in nasopharyngeal carcinoma patients
The combination of chemotherapy and radiation significantly improved the 5-year overall survival of patients with stage II nasopharyngeal carcinoma (NPC), according to a phase III study published Nov. 4 in the Journal of ...
Cancer
Nov 05, 2011 |
not rated yet |
0
Lung cancer patients with diabetes show prolonged survival
Lung cancer patients with diabetes tend to live longer than patients without diabetes, according to a Norwegian study published in the November issue of the Journal of Thoracic Oncology, the official publication of the International ...
Cancer
Oct 17, 2011 |
not rated yet |
0
Living donor liver transplantation improves survival over deceased donor transplants
New research shows liver transplantation candidates without hepatocellular carcinoma (HCC) derive a greater survival benefit from a living donor liver transplant (LDLT) than waiting for a deceased donor liver transplant (DDLT). ...
Other
Sep 27, 2011 |
not rated yet |
0
Zoledronic acid reduces the recurrence of breast cancer in post-menopausal women
A trial investigating the use of zoledronic acid to aid chemotherapy for breast cancer has found a significant benefit for post-menopausal women, according to results presented at the 2011 European Multidisciplinary Cancer ...
Cancer
Sep 25, 2011 |
not rated yet |
0
Abiraterone acetate improves fatigue in prostate cancer patients, says international clinical trial
Stockholm, Sweden: Men with prostate cancer that has spread to other parts of the body and that is resistant to hormone therapy suffer less from fatigue if they are treated with a combination of abiraterone acetate and prednisone, ...
Cancer
Sep 25, 2011 |
not rated yet |
0
Toxicity of aromatase inhibitors may explain lack of overall survival improvement
The toxicities associated with aromatase inhibitors (AIs) may explain the lack of overall survival improvement compared with tamoxifen, according to a study published August 22 in the Journal of The National Cancer Institute.
Cancer
Aug 22, 2011 |
5 / 5 (1) |
0
Radioembolization improves chance of survival for liver cancer patients
Analysis revealed survival for patients with hepatocellular carcinoma (HCC) is achievable using 90Y-resin microsphere radioembolization. The analysis conducted at multiple centers across Europe showed that the procedure is ...
Cancer
Aug 22, 2011 |
not rated yet |
0
Treatment provides dramatic survival benefit for hard-to-match kidney transplant patients
Hard-to-match kidney transplant candidates who receive a treatment designed to make their bodies more accepting of incompatible organs are twice as likely to survive eight years after transplant surgery as those who stay ...
Other
Jul 27, 2011 |
not rated yet |
0
Adrenaline use in cardiac arrest
Adrenaline has kept its place in cardiac arrest guidelines despite limited evidence for or against its use. The PACA (Placebo versus Adrenaline versus Cardiac Arrest) study by Jacobs and colleagues, soon to be published in ...
Cardiology
Jul 26, 2011 |
not rated yet |
0
Early transplants are no better than chemotherapy followed by transplant for NHL patients
Patients with a very aggressive form of non-Hodgkin lymphoma who receive a stem cell transplant after standard chemotherapy during their first remission have comparable survival rates to those who receive the same standard ...
Cancer
Jun 06, 2011 |
not rated yet |
0
Drug shown to significantly improve survival in men with metastatic prostate cancer
The final survival analysis of an international study of a new drug for prostate cancer has found an even greater median survival benefit than previously reported, and has established a new class of treatment for men with ...
Cancer
Jun 06, 2011 |
not rated yet |
0
